Latest Angiogenesis Stories
SAN DIEGO, June 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc.
INDIANAPOLIS, June 11, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the Phase III REACH trial of CYRAMZA(TM) (ramucirumab) in patients with hepatocellular carcinoma,
Two New Therapies Will Match Progression-Free Survival Improvements Required By Surveyed U.S.
-- REVEL Data Published in The Lancet, Presented at Annual ASCO Meeting -- CHICAGO, June 2, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from REVEL,
COMBO(TM) Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing HONG KONG, May 23, 2014 /PRNewswire/ --
Mechanisms of VEGF inhibitor-induced hypertension need to be better understood and guidelines developed to improve management.
MARIETTA, Ga., May 6, 2014 /PRNewswire/ -- MiMedx Group, Inc.
Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of a new clinical study supporting Nitrosigine™ inositol-stabilized arginine silicate, titled, “A Clinical Evaluation
2014 wound healing research grant awarded to the Wound Healing Society Foundation ORLANDO, Fla., April 23, 2014 /PRNewswire-USNewswire/ -- The Bates-Jensen Wound Reach Foundation and
INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S.
- The word or words serving to define another word or expression, as in a dictionary entry.